JERUSALEM, March 26, 2020 /PRNewswire/ -- Researchers at The Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods  to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools and diagnostic capabilities. A number of researchers submitted

PHILADELPHIA, March 26, 2020 /PRNewswire/ -- Microbiologists have long adopted the language of human settlement to describe how bacteria live and grow. A new study in 

NEW YORK, March 26, 2020 /PRNewswire/ -- New York-based real estate company Outpost Club, which operates 25 co-living communities across three states, announced today they will make new, dedicated housing available to the traveling doctors and nurses descending on New York, New Jersey and

CHICAGO, March 26, 2020 /PRNewswire/ -- As the global impact of COVID-19 increases, the scientific community continues to evaluate the clinical impact and healthcare needs of patients with lung disease, who are at increased risk for serious complications with COVID-19. The American Lung Association is supporting the health of those 36.6 million Americans living with

MELBOURNE, Australia, March 26, 2020 /PRNewswire/ -- Benitec Biopharma (ASX: BLT, NASDAQ: BNTC) ("Benitec" or the "Company"), a biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform combining RNA interference with gene therapy, today announced that in accordance with Australian Listing Rule 3.13.

LUND, Sweden, March 26, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") announced today that current Board Member, Hans Johansson, has acquired Immunovia shares for 500 KSEK on the open market and his total holding is now 28542 shares.About ImmunoviaImmunovia AB is a diagnostic company that is developing and

UPPSALA, Sweden, March 26, 2020 /PRNewswire/ --  Annual Report, including the Sustainability Report, for the 2019 fiscal year has been published. The Annual Report can be downloaded on the company's website,

HARRISBURG, Pa., March 26, 2020 /PRNewswire/ -- Geneia, a healthcare analytic solutions and services company that is simplifying the transition to value-based care, proudly announces its commitment to

NEW YORK, March 26, 2020 /PRNewswire/ -- The Lupus Research Alliance (LRA), the world's leading research organization dedicated to lupus research, continues to watch rapidly changing developments regarding COVID-19 and is closely monitoring the policies and actions of the federal government, healthcare agencies, medical organizations and the pharmaceutical industry

CRANFORD, N.J., March 26, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today the publication of an in vitro study for Mino-Lok®, the Company's antibiotic lock solution used to treat patients with central line